These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3215183)

  • 1. Pharmacokinetic studies of DISIDA disposition. II. Clinical studies.
    Love JE; Shaffer P; Fraser IA; Staubus AE; Lott JA; Hinkle G; Carey LC; Ellison EC; Fabri PJ
    Eur J Nucl Med; 1988; 14(9-10):436-40. PubMed ID: 3215183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic studies of DISIDA disposition. I. Animal studies.
    Fraser IA; Shaffer P; Love J; Staubus AE; Hinkle G; Olsen J; Carey LC; Fabri PJ; Ellison EC
    Eur J Nucl Med; 1988; 14(9-10):431-5. PubMed ID: 3215182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy.
    Gambhir SS; Hawkins RA; Huang SC; Hall TR; Busuttil RW; Phelps ME
    J Nucl Med; 1989 Sep; 30(9):1507-18. PubMed ID: 2769404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DISIDA kinetics measure liver function in dogs.
    Fraser IA; Shaffer P; Staubus AE; Tuttle S; Carey LC; Ellison EC
    Nucl Med Commun; 1989 Jun; 10(6):435-47. PubMed ID: 2771304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependency of 99mTc disofenin (DISIDA) in biliary tract imaging.
    Najafi A
    Int J Rad Appl Instrum B; 1987; 14(6):539-43. PubMed ID: 3429234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of technetium-99m DISIDA by bone metastasis from a hepatoma.
    Pons F; Lomeña F; Calvet X; Bruix J; Catafau A; Ginés A; Herranz R; Setoain J
    Clin Nucl Med; 1988 Apr; 13(4):280-2. PubMed ID: 2836119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.
    Calvet X; Pons F; Bruix J; Bru C; Lomeña F; Herranz R; Brugera M; Faus R; Rodes J
    J Nucl Med; 1988 Dec; 29(12):1916-20. PubMed ID: 2848112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of precise determination of technetium-labeled DISIDA concentrations for in vitro hepatocellular transport studies.
    Sasaki AW; Weaver A; Turner F; Krishnamurthy GT
    Int J Rad Appl Instrum A; 1992 Sep; 43(9):1061-4. PubMed ID: 1330985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A crossover study comparing the kinetics of Tc-99m-labeled diethyl- and diisopropyl-IDA.
    Hernandez M; Rosenthall L
    Clin Nucl Med; 1980 Aug; 5(8):352-8. PubMed ID: 7190477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of hepatobiliary scintigraphy with 99mTc-DISIDA in neonatal cholestasis.
    Spivak W; Sarkar S; Winter D; Glassman M; Donlon E; Tucker KJ
    J Pediatr; 1987 Jun; 110(6):855-61. PubMed ID: 3585600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidentally evaluating the status of renal function in technetium-99m DISIDA hepatobiliary imaging.
    Shih WJ; DeLand FH; Coupal JJ; Domstad PA
    Clin Nucl Med; 1986 Dec; 11(12):860-4. PubMed ID: 3815983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma, adenoma, and focal nodular hyperplasia.
    Kotzerke J; Schwarzrock R; Krischek O; Wiese H; Hundeshagen H
    J Nucl Med; 1989 Jul; 30(7):1278-80. PubMed ID: 2544700
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative Tc 99m - DISIDA hepatobiliary scintigraphy in normal and cirrhotic alcoholic subjects].
    Noguera EC; Wafa Hames A; Noguera EC
    Medicina (B Aires); 1995; 55(5 Pt 1):385-90. PubMed ID: 8728767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new cholescintigraphic agent: ruthenium-97-DISIDA.
    Zanzi I; Srivastava SC; Meinken GE; Robeson W; Mausner LF; Fairchild RG; Margouleff D
    Int J Rad Appl Instrum B; 1989; 16(4):397-403. PubMed ID: 2777581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of post-traumatic bile leak using technetium-99m DISIDA.
    Savitch I; Esser JD; Springolo E; Kew MC
    Clin Nucl Med; 1986 Dec; 11(12):873-4. PubMed ID: 3815987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pericholecystic hepatic activity sign in a normal DISIDA study. Case report.
    Thorstad BL; Sakow N; Dubovsky EV; Halpern NB
    Clin Nucl Med; 1987 Sep; 12(9):721-2. PubMed ID: 3665315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic disease of the liver studied by 99Tcm DISIDA and 99Tcm sulphur colloid imaging.
    Shih WJ; Domstad PA; Deland FH
    Nucl Med Commun; 1985 Mar; 6(3):173-8. PubMed ID: 4039807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic uptake of technetium-99m diisopropyl iminodiacetic acid (DISIDA) is not impaired by very high serum bilirubin levels.
    Ascher SA; Sarkar SD; Spivak WB
    Clin Nucl Med; 1988 Jan; 13(1):1-3. PubMed ID: 3349693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforated anterior duodenal ulcer: diagnosis with technetium Tc 99m DISIDA.
    Shaheen A; Becker SG; Sandler M
    South Med J; 1987 Mar; 80(3):394-6. PubMed ID: 3824033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of six new 99mTc-IDA agents for hepatobiliary imaging.
    Chervu LR; Joseph JA; Chun SB; Rolleston RE; Synnes EI; Thompson LM; Aldis AE; Rosenthall L
    Eur J Nucl Med; 1988; 14(9-10):441-5. PubMed ID: 3215184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.